Medicare Advantage Denial Rate Reduction Case Study
How we reduced Medicare Advantage claim denials from 19% to 4% for a home health agency with a predominantly MA payer mix—recovering $940K in annual revenue.
MA Denial Rate
Annual Revenue Protected
Appeal Success Rate
A/R Days Reduction
The Challenge
A home health agency in a high Medicare Advantage penetration market had watched its MA denial rate climb from 11% to 19% over 18 months as enrollment shifted from traditional Medicare to MA plans. The agency had historically managed billing under traditional Medicare's relatively standardized rules. The MA payer landscape—with its fragmented coverage policies, plan-specific prior authorization requirements, and documentation standards that frequently exceeded traditional Medicare requirements—was proving far more difficult to navigate.
The financial impact was substantial. With 68% of their claim volume coming from 14 different MA plans, a 19% denial rate translated to approximately $940,000 in annual revenue at risk. Their denial management team, built for traditional Medicare workflows, was overwhelmed: the appeals queue had grown to over 300 open cases with an average age of 67 days.
Root cause analysis was further complicated by the fact that denial reasons varied significantly across plans. What generated a denial from one plan was standard practice for another. Without payer-specific intelligence, the billing team was applying generic solutions to plan-specific problems.
Our Approach
Payer-by-Payer Denial Root Cause Analysis
We conducted a full denial analysis across all 14 MA plans, segmenting denials by payer, denial reason code, service type, and clinical grouping. This revealed that three plans accounted for 71% of all denials, and within those plans, four denial reasons accounted for 83% of the volume: missing or expired prior authorization (31%), documentation insufficient for medical necessity (27%), homebound status not adequately established (15%), and out-of-network provider billing errors (10%).
Payer-Specific Authorization and Documentation Workflows
We built authorization tracking workflows for each of the 14 plans, with plan-specific triggers for re-authorization and documentation checklists tailored to each plan's medical necessity criteria. For the three high-denial plans, we developed pre-submission documentation templates that map directly to the specific language and clinical evidence those plans' medical reviewers require for approval.
AI-Powered Pre-Submission Claim Screening
We deployed our denial prediction AI across all MA claims. The model—trained on this agency's historical denial data by payer—flags claims with high denial probability before submission and specifies the documentation gaps driving the risk. The team's pre-submission review focuses entirely on AI-flagged claims rather than reviewing every claim equally, dramatically improving efficiency.
Backlog Appeals and Peer-to-Peer Programs
We cleared the 300-case appeals backlog over 60 days using payer-specific appeal strategies developed from analysis of each plan's redetermination patterns. For the most resistant denials, we established a peer-to-peer review program connecting agency clinical staff with plan medical directors using condition-specific scripts that achieved a 78% reversal rate.
The Results
MA Denial Rate
79% reduction across all 14 MA plans
Annual Revenue Protected
From denial recovery and prevention
Appeal Success Rate
Using payer-specific appeal playbooks
A/R Days (MA Claims)
30-day reduction
Struggling with Medicare Advantage Denials?
As MA enrollment continues to grow, agencies without MA-specific billing workflows will see denial rates climb. Our payer-specific approach has helped agencies across the country reduce MA denials by 60–80%.
Schedule a Consultation